147 related articles for article (PubMed ID: 14585357)
1. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes.
Drayton S; Rowe J; Jones R; Vatcheva R; Cuthbert-Heavens D; Marshall J; Fried M; Peters G
Cancer Cell; 2003 Oct; 4(4):301-10. PubMed ID: 14585357
[TBL] [Abstract][Full Text] [Related]
2. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
3. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
Brookes S; Rowe J; Ruas M; Llanos S; Clark PA; Lomax M; James MC; Vatcheva R; Bates S; Vousden KH; Parry D; Gruis N; Smit N; Bergman W; Peters G
EMBO J; 2002 Jun; 21(12):2936-45. PubMed ID: 12065407
[TBL] [Abstract][Full Text] [Related]
4. The significance of p16INK4a in cell defenses against transformation.
Drayton S; Brookes S; Rowe J; Peters G
Cell Cycle; 2004 May; 3(5):611-5. PubMed ID: 15044857
[TBL] [Abstract][Full Text] [Related]
5. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
Milyavsky M; Shats I; Erez N; Tang X; Senderovich S; Meerson A; Tabach Y; Goldfinger N; Ginsberg D; Harris CC; Rotter V
Cancer Res; 2003 Nov; 63(21):7147-57. PubMed ID: 14612508
[TBL] [Abstract][Full Text] [Related]
6. The tumor-suppressive functions of the human INK4A locus.
Voorhoeve PM; Agami R
Cancer Cell; 2003 Oct; 4(4):311-9. PubMed ID: 14585358
[TBL] [Abstract][Full Text] [Related]
7. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
Huot TJ; Rowe J; Harland M; Drayton S; Brookes S; Gooptu C; Purkis P; Fried M; Bataille V; Hara E; Newton-Bishop J; Peters G
Mol Cell Biol; 2002 Dec; 22(23):8135-43. PubMed ID: 12417717
[TBL] [Abstract][Full Text] [Related]
8. Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.
Horiguchi M; Koyanagi S; Okamoto A; Suzuki SO; Matsunaga N; Ohdo S
Cancer Res; 2012 Jan; 72(2):395-401. PubMed ID: 22102693
[TBL] [Abstract][Full Text] [Related]
9. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
11. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
[TBL] [Abstract][Full Text] [Related]
12. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
13. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
14. Transformation of human and murine fibroblasts without viral oncoproteins.
Boehm JS; Hession MT; Bulmer SE; Hahn WC
Mol Cell Biol; 2005 Aug; 25(15):6464-74. PubMed ID: 16024784
[TBL] [Abstract][Full Text] [Related]
15. Unraveling human tumor suppressor pathways: a tale of the INK4A locus.
Voorhoeve PM; Agami R
Cell Cycle; 2004 May; 3(5):616-20. PubMed ID: 15044859
[TBL] [Abstract][Full Text] [Related]
16. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
[TBL] [Abstract][Full Text] [Related]
17. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
18. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
19. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
20. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
